Zaloguj się

Gotowe bibliografie tematyczne / Screening of Breast Cancer / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Screening of Breast Cancer.

Artykuły w czasopismach na temat „Screening of Breast Cancer”

Autor: Grafiati

Data publikacji: 6 września 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Screening of Breast Cancer”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Yamauchi, Hideko. "Breast Cancer Screening System in USA". Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, nr 2 (2012): 115–26. http://dx.doi.org/10.3804/jjabcs.21.115.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Arima, Yuriko. "Breast Cancer Screening Programme in the UK". Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, nr 2 (2012): 127–37. http://dx.doi.org/10.3804/jjabcs.21.127.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Chou, Yi-Hong. "Evolution of Breast Cancer Screening in Taiwan". Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, nr 2 (2012): 138–42. http://dx.doi.org/10.3804/jjabcs.21.138.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Gordon, Paula B. "The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening". Current Oncology 29, nr 5 (17.05.2022): 3595–636. http://dx.doi.org/10.3390/curroncol29050291.

Pełny tekst źródła

Streszczenie:

The purpose of breast cancer screening is to find cancers early to reduce mortality and to allow successful treatment with less aggressive therapy. Mammography is the gold standard for breast cancer screening. Its efficacy in reducing mortality from breast cancer was proven in randomized controlled trials (RCTs) conducted from the early 1960s to the mid 1990s. Panels that recommend breast cancer screening guidelines have traditionally relied on the old RCTs, which did not include considerations of breast density, race/ethnicity, current hormone therapy, and other risk factors. Women do not all benefit equally from mammography. Mortality reduction is significantly lower in women with dense breasts because normal dense tissue can mask cancers on mammograms. Moreover, women with dense breasts are known to be at increased risk. To provide equity, breast cancer screening guidelines should be created with the goal of maximizing mortality reduction and allowing less aggressive therapy, which may include decreasing the interval between screening mammograms and recommending consideration of supplemental screening for women with dense breasts. This review will address the issue of dense breasts and the impact on the stage of breast cancer at the time of diagnosis, and discuss options for supplemental screening.

Style APA, Harvard, Vancouver, ISO itp.

5

Schouten, L. J., J. Th Schlangen, J. M. de Rijke i A. L. M. Verbeek. "Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands". Journal of Medical Screening 5, nr 1 (1.03.1998): 37–41. http://dx.doi.org/10.1136/jms.5.1.37.

Pełny tekst źródła

Streszczenie:

Objective To evaluate the effect of a breast cancer screening programme by record linkage with the cancer registry. Setting Breast cancer screening programme in mid- and southern Limburg, the Netherlands. Method The data files of the breast cancer screening programme and the Maastricht Cancer Registry were linked in order to evaluate the effect of breast cancer screening. Only the first primary breast tumour was included in the evaluation. Results From 1990 until 1995 90 001 women participated in the first round of the breast cancer screening programme and 64 637 in subsequent rounds. After the introduction of screening the annual number of breast cancer diagnoses increased by almost 50%. The incidence decreased to previous levels after completion of the first screening round. Record linkage detected 219 interval cancers (within two and a half years of a screening), a proportionate incidence of 31% in the first year and 60% in the second year of the two-year interval between screenings. The incidence of node positive breast cancer was 1% lower in 1994 and 15% lower in 1995 than the incidence in the period 1987–90. Conclusions Evaluation of the effect of breast cancer screening in the Netherlands can be performed using routinely available cancer registry data. The results of this evaluation seem promising, but further studies are necessary to find ways to reduce the incidence of interval cancer.

Style APA, Harvard, Vancouver, ISO itp.

6

Calinescu, Gina, Corina Grigoriu, Athir Eddan, Nicolae Bacalbasa, Irina Balescu, Bianca-Margareta Mihai, Roxana Elena Bohiltea i Claudia Stoica. "Breast density and breast cancer". Romanian Journal of Medical Practice 16, S7 (30.12.2021): 29–32. http://dx.doi.org/10.37897/rjmp.2021.s7.9.

Pełny tekst źródła

Streszczenie:

Breast density is increasingly recognized as an independent risk factor for the development of breast cancer. It has been shown to be associated with a four-to sixfold increase a woman's risk of malignant breast disease. Increased breast density, as identified on mammography, is known to decrease the diagnostic sensitivity of the examination, which is of great concern to women at increased risk for breast cancer. Dense tissue has generally been associated with younger age and premenopausal status, with the assumption that breast density gradually decreases after menopause. However, the actual proportion of older women with dense breasts is unknown. Unfortunately, mammography is less accurate on dense breast tissue compared to fattier breast tissue. Multiple studies suggest a solution to this by demonstrating the ability of supplemental screening ultrasound to detect additional malignant lesions in women with dense breast tissue but with negative mammography. Improved screening methods for women with dense breasts are needed due to their increased risk of breast cancer and of failed early diagnosis by screening mammography.

Style APA, Harvard, Vancouver, ISO itp.

7

Ding, Rui, Yi Xiao, Miao Mo, Ying Zheng, Yi-Zhou Jiang i Zhi-Ming Shao. "Breast cancer screening and early diagnosis in Chinese women". Cancer Biology & Medicine 19, nr 4 (5.04.2022): 450–67. http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0676.

Pełny tekst źródła

Streszczenie:

Breast cancer is the most common malignant tumor in Chinese women, and its incidence is increasing. Regular screening is an effective method for early tumor detection and improving patient prognosis. In this review, we analyze the epidemiological changes and risk factors associated with breast cancer in China and describe the establishment of a screening strategy suitable for Chinese women. Chinese patients with breast cancer tend to be younger than Western patients and to have denser breasts. Therefore, the age of initial screening in Chinese women should be earlier, and the importance of screening with a combination of ultrasound and mammography is stressed. Moreover, Chinese patients with breast cancers have several ancestry-specific genetic features, and aiding in the determination of genetic screening strategies for identifying high-risk populations. On the basis of current studies, we summarize the development of risk-stratified breast cancer screening guidelines for Chinese women and describe the significant improvement in the prognosis of patients with breast cancer in China.

Style APA, Harvard, Vancouver, ISO itp.

8

P., Priyadarshini,, Sarathi, S. i Hemavathy, V. "Breast Cancer Screening". CARDIOMETRY, nr 24 (30.11.2022): 1000–1005. http://dx.doi.org/10.18137/cardiometry.2022.24.10001005.

Pełny tekst źródła

Streszczenie:

Breast cancer is the most frequent cancer in women, impacting one out of every eight women at some point in their lives. Despite the fact that it is more frequent in older women, breast cancer seldom strikes women under the age of 45. Women under the age of 45 account for around 9% of all new cases of breast cancer in the United States. The most important methods for preventing breast cancer deaths are early detection and cutting-edge cancer treatment. Breast cancer that is detected early, when it is little and hasn’t spread, is easier to treat. The most accurate method for identifying breast cancer early is through frequent screening examinations. According to the American Cancer Society, screening is recommended for both women who are at medium risk of breast cancer and those who are at high risk. Breast cancer screening tests are used to detect the disease before symptoms such as a palpable lump appear. Screening tests and exams are used to identify illness in persons who do not exhibit symptoms. Clinical and self-breast examinations, mammography, genetic screening, ultrasound, and magnetic resonance imaging have all been used as screening treatments.

Style APA, Harvard, Vancouver, ISO itp.

9

Bukhari, Hassan, Asim Shaukat i Nosheen Ahmad. "BREAST CANCER SCREENING;". Professional Medical Journal 24, nr 01 (18.01.2017): 42–46. http://dx.doi.org/10.29309/tpmj/2017.24.01.400.

Pełny tekst źródła

Streszczenie:

Objectives: To compare the efficacy of Magnetic resonance imaging andMammography for Breast-Cancer Screening in high risk Women with a Familial or GeneticPredisposition. Study Design: Cross-sectional study. Setting: Department of Radiology AlliedHospital, Faisalabad. Duration: From January 2012 to December 2014, Sample size: 299.Methods: A total of 299 females at high risk of breast cancer were included in this study andthey underwent screening rounds of Mammogram and contrast enhanced dynamic breastMRI once a year with independent readings. Both the imaging modalities were interpreted byexperience radiologist and all the images were categorized using Breast Imaging Reportingand Data System. In each patient, histopathology results were considered the standard criteriafor the calculation of the sensitivity, specificity for both Mammogram and Breast MRI lesions.Results: Mean age of the patients was 46.69±11.86 years. Mammography revealed 11 (3.68%)true positive breast lesions, 22 (7.36%) false positive lesion, 247 (82.61%) true negative and19 (6.35%) false negative lesions yielding the sensitivity of 36.67% and diagnostic accuracy of86.3%. Dynamic breast MRI revealed 28 (9.36%) true positive breast lesions with 5 (1.67%) falsepositive, 264 (88.29%) true negative and 2 (0.67%) false negative lesions yielding sensitivity of93.3%,specificity of 98.14%,PPV=84.85%,NPV=99.25% and diagnostic accuracy of 97.66%.MRI breast was significantly more sensitive (93.3 vs. 36.67%) and accurate (97.66 vs. 86.3%)than mammography. Conclusion: MRI is more sensitive than mammography in detectingtumors in women with an inherited susceptibility to breast cancer.

Style APA, Harvard, Vancouver, ISO itp.

10

Lynge, Elsebeth, Ilse Vejborg, Zorana Andersen, My von Euler-Chelpin i George Napolitano. "Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening". Journal of Clinical Medicine 8, nr 11 (19.11.2019): 2021. http://dx.doi.org/10.3390/jcm8112021.

Pełny tekst źródła

Streszczenie:

Background: Attention in the 2000s on the importance of mammographic density led us to study screening sensitivity, breast cancer incidence, and associations with risk factors by mammographic density in Danish breast cancer screening programs. Here, we summarise our approaches and findings. Methods: Dichotomized density codes: fatty, equal to BI-RADS density code 1 and part of 2, and other mixed/dense data from the 1990s—were available from two counties, and BI-RADS density codes from one region were available from 2012/13. Density data were linked with data on vital status, incident breast cancer, and potential risk factors. We calculated screening sensitivity by combining data on screen-detected and interval cancers. We used cohorts to study high density as a predictor of breast cancer risk; cross-sectional data to study the association between life style factors and density, adjusting for age and body mass index (BMI); and time trends to study the prevalence of high density across birth cohorts. Results: Sensitivity decreased with increasing density from 78% in women with BI-RADS 1 to 47% in those with BI-RADS 4. For women with mixed/dense compared with those with fatty breasts, the rate ratio of incident breast cancer was 2.45 (95% CI 2.14–2.81). The percentage of women with mixed/dense breasts decreased with age, but at a higher rate the later the women were born. Among users of postmenopausal hormone therapy, the percentage of women with mixed/dense breasts was higher than in non-users, but the patterns across birth cohorts were similar. The occurrence of mixed/dense breast at screening age decreased by a z-score unit of BMI at age 13—odds ratio (OR) 0.56 (95% CI 0.53–0.58)—and so did breast cancer risk and hazard ratio (HR) 0.92 (95% CI 0.84–1.00), but it changed to HR 1.01 (95% CI 0.93–1.11) when controlled for density. Age and BMI adjusted associations between life style factors and density were largely close to unity; physical activity OR 1.06 (95% CI 0.93–1.21); alcohol consumption OR 1.01 (95% CI 0.81–1.27); air pollution OR 0.96 (95% 0.93–1.01) per 20 μg/m3; and traffic noise OR 0.94 (95% CI 0.86–1.03) per 10 dB. Weak negative associations were seen for diabetes OR 0.61 (95% CI 0.40–0.92) and cigarette smoking OR 0.86 (95% CI 0.75–0.99), and a positive association was found with hormone therapy OR 1.24 (95% 1.14–1.35). Conclusion: Our data indicate that breast tissue in middle-aged women is highly dependent on childhood body constitution while adult life-style plays a modest role, underlying the need for a long-term perspective in primary prevention of breast cancer.

Style APA, Harvard, Vancouver, ISO itp.

11

Barton, Mary B. "Breast cancer screening". Postgraduate Medicine 118, nr 2 (sierpień 2005): 27–46. http://dx.doi.org/10.3810/pgm.2005.08.1692.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Zorbas, Helen M. "Breast cancer screening". Medical Journal of Australia 178, nr 12 (czerwiec 2003): 651–52. http://dx.doi.org/10.5694/j.1326-5377.2003.tb05397.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Warner, Elizabeth A. "BREAST CANCER SCREENING". Primary Care: Clinics in Office Practice 19, nr 3 (wrzesień 1992): 575–88. http://dx.doi.org/10.1016/s0095-4543(21)00939-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Cooper, Nora. "Breast cancer screening". Nursing Standard 13, nr 31 (21.04.1999): 49–52. http://dx.doi.org/10.7748/ns1999.04.13.31.49.c7471.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Freimanis, Rita I., i Margaret Yacobozzi. "Breast Cancer Screening". North Carolina Medical Journal 75, nr 2 (marzec 2014): 117–20. http://dx.doi.org/10.18043/ncm.75.2.117.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Tabár, László, i Peter B. Dean. "Breast cancer screening". Medical Journal of Australia 154, nr 7 (kwiecień 1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121204.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Kearsley, John H., i Cherrell Hirst. "Breast cancer screening". Medical Journal of Australia 154, nr 7 (kwiecień 1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121205.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Cohen, Jonathan, i Joseph Cohen. "Breast cancer screening". Medical Journal of Australia 154, nr 7 (kwiecień 1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121206.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Freilich, Herbert. "Breast cancer screening". Medical Journal of Australia 154, nr 11 (czerwiec 1991): 781–82. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121347.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Tabár, László, i Peter B. Dean. "Breast cancer screening". Medical Journal of Australia 154, nr 12 (czerwiec 1991): 853–54. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121395.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Warner, Ellen. "Breast-Cancer Screening". New England Journal of Medicine 365, nr 11 (15.09.2011): 1025–32. http://dx.doi.org/10.1056/nejmcp1101540.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Ellman, Ruth. "Breast Cancer Screening". Journal of the Royal Society of Medicine 80, nr 11 (listopad 1987): 665–66. http://dx.doi.org/10.1177/014107688708001101.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Donald Acheson, E. "Breast Cancer Screening". Journal of the Royal Society of Medicine 82, nr 8 (sierpień 1989): 455–57. http://dx.doi.org/10.1177/014107688908200804.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Owens, R. Glynn, i Jennifer J. Ashcroft. "Breast Cancer Screening". Journal of Psychosocial Oncology 4, nr 4 (26.02.1987): 15–26. http://dx.doi.org/10.1300/j077v04n04_02.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

GEMIGNANI, MARY L. "Breast Cancer Screening". Clinical Obstetrics and Gynecology 54, nr 1 (marzec 2011): 125–32. http://dx.doi.org/10.1097/grf.0b013e318208020d.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

FELDMAN, ELIZABETH D., BRIDGET A. OPPONG i SHAWNA C. WILLEY. "Breast Cancer Screening". Clinical Obstetrics and Gynecology 55, nr 3 (wrzesień 2012): 662–70. http://dx.doi.org/10.1097/grf.0b013e31825ca884.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

EDDY, D. M. "Breast Cancer Screening". JNCI Journal of the National Cancer Institute 81, nr 3 (1.02.1989): 234–35. http://dx.doi.org/10.1093/jnci/81.3.234.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Palmieri, C., S. Fishpool i H. O. Dickinson. "Breast cancer screening". BMJ 321, nr 7260 (2.09.2000): 567. http://dx.doi.org/10.1136/bmj.321.7260.567/b.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Witcombe, J. B. "Breast cancer screening". Clinical Radiology 44, nr 4 (październik 1991): 287. http://dx.doi.org/10.1016/s0009-9260(05)80203-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Kirkpatrick, A. E. "Breast cancer screening". Clinical Radiology 44, nr 4 (październik 1991): 287. http://dx.doi.org/10.1016/s0009-9260(05)80204-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Wilbanks, Sandy. "Breast Cancer Screening". Journal for Nurse Practitioners 13, nr 4 (kwiecień 2017): e217. http://dx.doi.org/10.1016/j.nurpra.2017.03.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Wilbanks, Sandy. "Breast Cancer Screening". Journal for Nurse Practitioners 13, nr 4 (kwiecień 2017): e219. http://dx.doi.org/10.1016/j.nurpra.2017.03.002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Jatoi, Ismail. "Breast cancer screening". American Journal of Surgery 177, nr 6 (czerwiec 1999): 518–24. http://dx.doi.org/10.1016/s0002-9610(99)00096-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Fentiman, IanS. "BREAST CANCER SCREENING". Lancet 331, nr 8598 (czerwiec 1988): 1336. http://dx.doi.org/10.1016/s0140-6736(88)92149-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Autier, Philippe. "Breast cancer screening". European Journal of Cancer 47 (wrzesień 2011): S133—S146. http://dx.doi.org/10.1016/s0959-8049(11)70157-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Amadori, D. "Breast cancer screening". European Journal of Cancer 34 (wrzesień 1998): S91. http://dx.doi.org/10.1016/s0959-8049(98)80369-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Witcombe, J. B., Nicholas Wald, Christopher Frost, Howard Cuckle i Peter Oppenheimer. "BREAST CANCER SCREENING". Lancet 329, nr 8537 (kwiecień 1987): 859. http://dx.doi.org/10.1016/s0140-6736(87)91632-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Moss, Sue, Jocelyn Chamberlain, Ruth Ellman, Anne Ludbrook, Anne Rodway i A. F. Macdonald. "BREAST CANCER SCREENING". Lancet 329, nr 8542 (maj 1987): 1153–54. http://dx.doi.org/10.1016/s0140-6736(87)91716-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Vanderburgh, David. "Breast cancer screening". Politics and the Life Sciences 37, nr 1 (2018): 135–40. http://dx.doi.org/10.1017/pls.2018.3.

Pełny tekst źródła

Streszczenie:

Cass R. Sunstein’s 2016 bookThe Ethics of Influence: Government in the Age of Behavioral Scienceprovides an extremely informative introduction to the science and ethics of the exercise of “influence” over others. As a longtime physician employed in both the public and private sectors, I now recognize that most of my formal training has been in the hard sciences, with little, if any, training in the appropriate influence of the decision-making processes of my patients and/or other health care professionals in institutional settings. Breast cancer screening is an excellent example of the conflicts of modern medicine, highlighting our collective inability to effectively “nudge” others in the pursuit of health and/or organizational effectiveness and efficiency. Using the framework of Sunstein’s ethical values of welfare, autonomy, dignity, and self-government, I discuss many of the conflicting issues in a nationwide breast cancer screening program and the effects of these issues on client nudging to determine whether mammography screening is ethical.

Style APA, Harvard, Vancouver, ISO itp.

40

Jordan, Veronica, Muneeza Khan i Donna Prill. "Breast Cancer Screening". Primary Care: Clinics in Office Practice 46, nr 1 (marzec 2019): 97–115. http://dx.doi.org/10.1016/j.pop.2018.10.010.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Thornton, Hazel. "Breast cancer screening". Lancet 351, nr 9096 (styczeń 1998): 145. http://dx.doi.org/10.1016/s0140-6736(05)78108-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Leitch, A. Marilyn. "Breast Cancer Screening". Surgical Oncology Clinics of North America 8, nr 4 (październik 1999): 657–72. http://dx.doi.org/10.1016/s1055-3207(18)30181-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Overmoyer, Beth. "BREAST CANCER SCREENING". Medical Clinics of North America 83, nr 6 (listopad 1999): 1443–66. http://dx.doi.org/10.1016/s0025-7125(05)70174-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Fuller, Mackenzie S., Christoph I. Lee i Joann G. Elmore. "Breast Cancer Screening". Medical Clinics of North America 99, nr 3 (maj 2015): 451–68. http://dx.doi.org/10.1016/j.mcna.2015.01.002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Sirovich, Brenda E., i Harold C. Sox. "BREAST CANCER SCREENING". Surgical Clinics of North America 79, nr 5 (październik 1999): 961–90. http://dx.doi.org/10.1016/s0039-6109(05)70056-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Skrabanek, Petr, N. E. Day, L. Tabár, G. Fagerberg i A. D. Hibberd. "BREAST CANCER SCREENING". Lancet 326, nr 8446 (lipiec 1985): 94–95. http://dx.doi.org/10.1016/s0140-6736(85)90194-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Skrabanek, Petr. "BREAST CANCER SCREENING". Lancet 326, nr 8461 (październik 1985): 941. http://dx.doi.org/10.1016/s0140-6736(85)90866-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Euhus, David, Philip A. Di Carlo i Nagi F. Khouri. "Breast Cancer Screening". Surgical Clinics of North America 95, nr 5 (październik 2015): 991–1011. http://dx.doi.org/10.1016/j.suc.2015.05.008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Nielsen, Beverly B. "Breast cancer screening". Seminars in Oncology Nursing 7, nr 3 (sierpień 1991): 161–65. http://dx.doi.org/10.1016/0749-2081(91)90028-n.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Miller, Redonda G. "Breast cancer screening". Journal of General Internal Medicine 16, nr 3 (marzec 2001): 206–7. http://dx.doi.org/10.1111/j.1525-1497.2001.10119.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!